Or a Tale of two Pricings for the Same Drug, One for the US and another for other countries. Eventually Medicare is going to get around to negotiating with these ten companies for the ten drugs in question here. As taken from one section of Lever News, I have reposted the finding of those ten […]

Jeff Jacoby had an interesting article in the Boston Globe on Sunday where he argue that if the demand for something doubled the price must increase—it is basic introductory economics. What price is too high for a miracle drug? His argument is so typical of how so many columnist and/or bloggers demonstrate that a little […]